SI1658062T1 - Alfa aminoamidni derivati uporabni kot protivnetna sredstva - Google Patents
Alfa aminoamidni derivati uporabni kot protivnetna sredstvaInfo
- Publication number
- SI1658062T1 SI1658062T1 SI200431379T SI200431379T SI1658062T1 SI 1658062 T1 SI1658062 T1 SI 1658062T1 SI 200431379 T SI200431379 T SI 200431379T SI 200431379 T SI200431379 T SI 200431379T SI 1658062 T1 SI1658062 T1 SI 1658062T1
- Authority
- SI
- Slovenia
- Prior art keywords
- inflammatory agents
- alpha
- derivatives useful
- aminoamide derivatives
- aminoamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49772203P | 2003-08-25 | 2003-08-25 | |
EP04728870A EP1658062B1 (en) | 2003-08-25 | 2004-04-22 | Alpha-aminoamide derivatives useful as anti-inflammatory agents |
PCT/IB2004/001574 WO2005018627A1 (en) | 2003-08-25 | 2004-04-22 | Alpha-aminoamide derivatives useful as anti-inflammatory agents |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1658062T1 true SI1658062T1 (sl) | 2010-05-31 |
Family
ID=34216147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200431379T SI1658062T1 (sl) | 2003-08-25 | 2004-04-22 | Alfa aminoamidni derivati uporabni kot protivnetna sredstva |
Country Status (21)
Country | Link |
---|---|
US (2) | US20070276046A1 (sl) |
EP (1) | EP1658062B1 (sl) |
JP (1) | JP5042625B2 (sl) |
KR (1) | KR101233711B1 (sl) |
CN (1) | CN1842328A (sl) |
AT (1) | ATE457724T1 (sl) |
AU (1) | AU2004266494B2 (sl) |
BR (1) | BRPI0413982A (sl) |
CA (1) | CA2536764C (sl) |
CY (1) | CY1109992T1 (sl) |
DE (1) | DE602004025586D1 (sl) |
DK (1) | DK1658062T3 (sl) |
ES (1) | ES2339021T3 (sl) |
IL (1) | IL173886A (sl) |
NO (1) | NO335245B1 (sl) |
NZ (1) | NZ545502A (sl) |
PL (1) | PL1658062T3 (sl) |
PT (1) | PT1658062E (sl) |
RU (1) | RU2396251C2 (sl) |
SI (1) | SI1658062T1 (sl) |
WO (1) | WO2005018627A1 (sl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE602004025586D1 (de) * | 2003-08-25 | 2010-04-01 | Newron Pharm Spa | Alpha-aminoamid derivate zur verwendung als anti-inflammatorische wirkstoffe |
EP1557166A1 (en) | 2004-01-21 | 2005-07-27 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders |
ES2347581T3 (es) * | 2004-09-10 | 2010-11-02 | Newron Pharmaceuticals S.P.A. | Uso de (r)-(halobenciloxi)bencilamino-propanamidas como moduladores selectivos del canal de sodio y/o calcio. |
AU2006329040C1 (en) * | 2005-12-22 | 2011-12-08 | Newron Pharmaceuticals S.P.A. | 2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators |
NZ572798A (en) | 2006-06-19 | 2011-11-25 | Newron Pharm Spa | Process for the production of safinamide and ralfinamide |
CN101687773B (zh) | 2007-06-15 | 2014-07-30 | 纽朗制药有限公司 | 取代的2-[2-(苯基)乙氨基]烷酰胺衍生物及其作为钠和/或钙通道调节剂的应用 |
EP2229351B1 (en) | 2007-12-11 | 2017-11-08 | Newron Pharmaceuticals S.p.A. | Process for the production of 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides with high purity degree |
PT2563355T (pt) | 2010-04-27 | 2016-09-02 | Newron Pharm Spa | Processo para a produção de sais metanossulfonato de ralfinamida ou dos seus enantiómeros r |
RU2449805C1 (ru) | 2011-01-27 | 2012-05-10 | Общество С Ограниченной Ответственностью "Гармония" | Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования |
DE102012108965B4 (de) | 2012-09-24 | 2014-08-14 | Exscitron Gmbh | Stromquelle mit verbesserter Dimmvorrichtung |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94466A (en) * | 1989-05-25 | 1995-01-24 | Erba Carlo Spa | Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation |
GB9726987D0 (en) * | 1997-12-22 | 1998-02-18 | Glaxo Group Ltd | Compounds |
GB9727523D0 (en) * | 1997-12-31 | 1998-02-25 | Pharmacia & Upjohn Spa | Alpha-aminoamide derivatives useful as analgesic agents |
SE9801494D0 (sv) * | 1998-04-28 | 1998-04-28 | Astra Pharma Prod | Novel use |
GB9930079D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
ES2281431T3 (es) * | 2000-07-27 | 2007-10-01 | Pharmacia Corporation | Terapia de combinacion con antagonista epoxi-esteroidal de aldosterona y bloqueador de los canales de calcio para tratamiento de la insuficiencia cardiaca congestiva. |
PT1423168E (pt) * | 2001-09-03 | 2006-05-31 | Newron Pharm Spa | Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico |
US6897319B2 (en) * | 2001-12-27 | 2005-05-24 | Ortho-Mcneil Pharmaceutical, Inc. | Useful aroyl pyrrole heteroaryl methanones and methanols |
EP1438956A1 (en) * | 2003-01-16 | 2004-07-21 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful as antimigraine agents |
AU2004207009A1 (en) * | 2003-01-30 | 2004-08-12 | Dynogen Pharmaceuticals, Inc. | Use of sodium channel modulators for treating gastrointestinal tract disorders |
AU2004207010A1 (en) * | 2003-01-30 | 2004-08-12 | Dynogen Pharmaceuticals, Inc. | Methods of treating lower urinary tract disorders using sodium channel modulators |
AR044007A1 (es) * | 2003-04-11 | 2005-08-24 | Newron Pharmaceuticals Inc | Metodos para el tratamiento de la enfermedad de parkinson |
DE602004025586D1 (de) * | 2003-08-25 | 2010-04-01 | Newron Pharm Spa | Alpha-aminoamid derivate zur verwendung als anti-inflammatorische wirkstoffe |
EP1588704A1 (en) * | 2004-04-22 | 2005-10-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders |
ES2347581T3 (es) * | 2004-09-10 | 2010-11-02 | Newron Pharmaceuticals S.P.A. | Uso de (r)-(halobenciloxi)bencilamino-propanamidas como moduladores selectivos del canal de sodio y/o calcio. |
AU2006329040C1 (en) * | 2005-12-22 | 2011-12-08 | Newron Pharmaceuticals S.P.A. | 2 -Phenylethylamino derivatives as calcium and/or sodium channel modulators |
EP1870097A1 (en) * | 2006-06-15 | 2007-12-26 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders |
NZ572798A (en) * | 2006-06-19 | 2011-11-25 | Newron Pharm Spa | Process for the production of safinamide and ralfinamide |
CN101687773B (zh) * | 2007-06-15 | 2014-07-30 | 纽朗制药有限公司 | 取代的2-[2-(苯基)乙氨基]烷酰胺衍生物及其作为钠和/或钙通道调节剂的应用 |
EP2229351B1 (en) * | 2007-12-11 | 2017-11-08 | Newron Pharmaceuticals S.p.A. | Process for the production of 2-[4-(3- or 2-fluorobenzyloxy)benzylamino]propanamides with high purity degree |
CN101903021B (zh) * | 2007-12-19 | 2012-11-14 | 纽朗制药有限公司 | 用于治疗精神病的α-氨基酰胺衍生物 |
-
2004
- 2004-04-22 DE DE602004025586T patent/DE602004025586D1/de not_active Expired - Lifetime
- 2004-04-22 WO PCT/IB2004/001574 patent/WO2005018627A1/en active Application Filing
- 2004-04-22 IL IL173886A patent/IL173886A/en active IP Right Grant
- 2004-04-22 CA CA2536764A patent/CA2536764C/en not_active Expired - Lifetime
- 2004-04-22 DK DK04728870.9T patent/DK1658062T3/da active
- 2004-04-22 NZ NZ545502A patent/NZ545502A/en unknown
- 2004-04-22 SI SI200431379T patent/SI1658062T1/sl unknown
- 2004-04-22 AT AT04728870T patent/ATE457724T1/de active
- 2004-04-22 PL PL04728870T patent/PL1658062T3/pl unknown
- 2004-04-22 AU AU2004266494A patent/AU2004266494B2/en not_active Expired
- 2004-04-22 EP EP04728870A patent/EP1658062B1/en not_active Expired - Lifetime
- 2004-04-22 BR BRPI0413982-8A patent/BRPI0413982A/pt not_active Application Discontinuation
- 2004-04-22 ES ES04728870T patent/ES2339021T3/es not_active Expired - Lifetime
- 2004-04-22 JP JP2006524432A patent/JP5042625B2/ja not_active Expired - Lifetime
- 2004-04-22 PT PT04728870T patent/PT1658062E/pt unknown
- 2004-04-22 RU RU2006105634/04A patent/RU2396251C2/ru active
- 2004-04-22 KR KR1020067003725A patent/KR101233711B1/ko active IP Right Grant
- 2004-04-22 CN CNA2004800242753A patent/CN1842328A/zh active Pending
- 2004-04-22 US US10/569,403 patent/US20070276046A1/en not_active Abandoned
-
2006
- 2006-02-23 NO NO20060896A patent/NO335245B1/no unknown
-
2009
- 2009-08-20 US US12/544,456 patent/US20100016440A1/en not_active Abandoned
-
2010
- 2010-04-16 CY CY20101100342T patent/CY1109992T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
RU2006105634A (ru) | 2006-08-10 |
CA2536764C (en) | 2013-09-17 |
IL173886A (en) | 2012-09-24 |
ES2339021T3 (es) | 2010-05-14 |
WO2005018627A8 (en) | 2005-09-01 |
NO335245B1 (no) | 2014-10-27 |
EP1658062A1 (en) | 2006-05-24 |
RU2396251C2 (ru) | 2010-08-10 |
CA2536764A1 (en) | 2005-03-03 |
JP2007503424A (ja) | 2007-02-22 |
NZ545502A (en) | 2010-04-30 |
AU2004266494B2 (en) | 2010-04-08 |
KR20060128825A (ko) | 2006-12-14 |
JP5042625B2 (ja) | 2012-10-03 |
ATE457724T1 (de) | 2010-03-15 |
US20070276046A1 (en) | 2007-11-29 |
NO20060896L (no) | 2006-03-09 |
WO2005018627A1 (en) | 2005-03-03 |
BRPI0413982A (pt) | 2006-11-07 |
DE602004025586D1 (de) | 2010-04-01 |
EP1658062B1 (en) | 2010-02-17 |
KR101233711B1 (ko) | 2013-02-18 |
AU2004266494A1 (en) | 2005-03-03 |
CY1109992T1 (el) | 2014-09-10 |
DK1658062T3 (da) | 2010-05-31 |
PL1658062T3 (pl) | 2010-07-30 |
PT1658062E (pt) | 2010-03-31 |
US20100016440A1 (en) | 2010-01-21 |
CN1842328A (zh) | 2006-10-04 |
IL173886A0 (en) | 2006-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1109992T1 (el) | Παραγωγα του αλφα-αμιναμιδιου χρησιμα ως αντιφλεγμονωδη μεσα | |
RS20050946A (en) | Pyrrolodihydroisoquinolines as pde10 inhibitors | |
TW200640924A (en) | VEGF-R2 inhibitors and methods | |
UA85559C2 (en) | Aminobenzophenone compounds | |
EA200501333A1 (ru) | 5,7-ДИАМИНОПИРАЗОЛО[4,3-d]ПИРИМИДИНЫ, ПОЛЕЗНЫЕ ПРИ ЛЕЧЕНИИ ГИПЕРТЕНЗИИ | |
NO20082594L (no) | Pyrimidinylbenzotiofenforbindelser | |
EP1919302B8 (en) | Food comprising silicon | |
NO20062860L (no) | Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet | |
EA200702510A1 (ru) | Способы защиты от апоптоза с применением липопептидов | |
HK1115590A1 (en) | Triazolophthalazines | |
MX2010000098A (es) | Derivados de guanina policiclicos y sus metodos de uso. | |
UA90698C2 (en) | Triazole substituted aminobenzophenone compounds | |
RS50720B (sr) | 3,11 b-cis-dihidrotetrabenazin za lečenje proliferativne bolesti ili inflamacije | |
IL191751A0 (en) | Pyrrolo[2,3-c]pyridine derivatives | |
HK1133642A1 (en) | Azaadamantane ester and carbamate derivatives and methods of use thereof | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
WO2004110990A3 (en) | Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 | |
RS20070095A (en) | Alkyliden-tetrahydronaphthalene derivatives, method for their production and their use as anti-inflammatory agents | |
NO20063293L (no) | Farmasoytiske forbindelser | |
TW200503703A (en) | Pharmaceutical compositions | |
EP1883624A4 (en) | D-HOMOANDROSTA-17-YL CARBAMATE DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR LIGANDS | |
WO2006010077A3 (en) | Prodrugs of lonidamine and lonidamine analogs | |
TW200700389A (en) | 5h-benzocycloheptene derivatives, process for their production and their use as anti-inflammatory agents | |
TW200628453A (en) | Triazole substituted aminobenzophenone compounds | |
MY143246A (en) | Triazole substituted aminobensophenone compounds |